Authorized purpose: View, post-process, and qualitatively and quantitatively evaluate cardiovascular MR and CT images in DICOM format to obtain diagnostic information as part of a comprehensive diagnostic decision-making process.
Clinical role
Post-acquisition viewing and post-processing with qualitative and quantitative measurement, semi-automatic segmentation, calcium scoring, vessel analysis, and reporting for clinician-led diagnostic review.
Images and patients
CT/CTA; MRI · Cardiovascular system; heart, coronary and adjacent vessels, and cardiac valves
Key limitation
Keep in mind: The device must not be used to view or analyze non-cardiac body parts. The semi-automated machine-learning modules are intended for adults. Results support a comprehensive physician decision process and do not replace clinician review. The packet reports no clinical study was necessary for substantial equivalence; module-specific validation results are not a global diagnostic-performance claim.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: View, post-process, and qualitatively and quantitatively evaluate cardiovascular MR and CT images in DICOM format to obtain diagnostic information as part of a comprehensive diagnostic decision-making process.
Which images or clinical context are in scope?Modality: CT/CTA; MRI Anatomy or clinical context: Cardiovascular system; heart, coronary and adjacent vessels, and cardiac valves Input: Previously acquired cardiovascular MR and CT images in DICOM format from cardiovascular MR or CT scanners; the packet limits analysis to cardiac images and states that the machine-learning modules are intended for adults.
Who uses it?Intended users: Qualified medical professionals experienced in examining and evaluating cardiovascular MR or CT images.
What does the software produce?Output: Display and reconstruction tools plus measurements including distance, area, volume, mass, signal intensity, Agatston score, stenosis, velocity, strain, cardiac function metrics, and semi-automatic cardiac segmentation; also calcium scoring, coronary centerline analysis, vessel stenosis evaluation, lesion reporting, and key images.
What is its most important limitation?Key limitation: The device must not be used to view or analyze non-cardiac body parts. The semi-automated machine-learning modules are intended for adults. Results support a comprehensive physician decision process and do not replace clinician review. The packet reports no clinical study was necessary for substantial equivalence; module-specific validation results are not a global diagnostic-performance claim.
Clinical takeaway. Clinical role: View, post-process, and qualitatively and quantitatively evaluate cardiovascular MR and CT images in DICOM format to obtain diagnostic information as part of a comprehensive diagnostic decision-making process.
Evidence takeaway. Evidence from the reviewed source record: FDA verification and validation covered non-ML outputs and machine-learning modules. Validation used 235 anonymized patient images with component-specific counts: 70 coronary, 102 calcium, 63 SAX function, 63 each for 2-, 3-, and 4-chamber LAX function, and 252 function-classification samples. Reported ranges were 97%-100% series classification, 7%-10% SAX and 5%-9% LAX volumetric MAE, 86%-99% calcium classification, 82%-94% coronary centerline performance, and 98%-100% coronary-mask performance. Cardiac CT segmentation reported LV MAE below 10%, Dice above 86%, Hausdorff distance below 9.5 mm, and EF bias 1.3% (95% CI -12 to 14); RV MAE below 18%, Dice above 85%, Hausdorff distance below 18 mm, and EF bias -5.5% (95% CI -15 to 4.4); LV-myocardium MAE below 17%, Dice above 82%, and Hausdorff distance below 15 mm.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
View, post-process, and qualitatively and quantitatively evaluate cardiovascular MR and CT images in DICOM format to obtain diagnostic information as part of a comprehensive diagnostic decision-making process.
Post-acquisition viewing and post-processing with qualitative and quantitative measurement, semi-automatic segmentation, calcium scoring, vessel analysis, and reporting for clinician-led diagnostic review.
Previously acquired cardiovascular MR and CT images in DICOM format from cardiovascular MR or CT scanners; the packet limits analysis to cardiac images and states that the machine-learning modules are intended for adults.
Display and reconstruction tools plus measurements including distance, area, volume, mass, signal intensity, Agatston score, stenosis, velocity, strain, cardiac function metrics, and semi-automatic cardiac segmentation; also calcium scoring, coronary centerline analysis, vessel stenosis evaluation, lesion reporting, and key images.
The device must not be used to view or analyze non-cardiac body parts. The semi-automated machine-learning modules are intended for adults. Results support a comprehensive physician decision process and do not replace clinician review. The packet reports no clinical study was necessary for substantial equivalence; module-specific validation results are not a global diagnostic-performance claim.
FDA verification and validation covered non-ML outputs and machine-learning modules. Validation used 235 anonymized patient images with component-specific counts: 70 coronary, 102 calcium, 63 SAX function, 63 each for 2-, 3-, and 4-chamber LAX function, and 252 function-classification samples. Reported ranges were 97%-100% series classification, 7%-10% SAX and 5%-9% LAX volumetric MAE, 86%-99% calcium classification, 82%-94% coronary centerline performance, and 98%-100% coronary-mask performance. Cardiac CT segmentation reported LV MAE below 10%, Dice above 86%, Hausdorff distance below 9.5 mm, and EF bias 1.3% (95% CI -12 to 14); RV MAE below 18%, Dice above 85%, Hausdorff distance below 18 mm, and EF bias -5.5% (95% CI -15 to 4.4); LV-myocardium MAE below 17%, Dice above 82%, and Hausdorff distance below 15 mm.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
FDA verification and validation covered non-ML outputs and machine-learning modules. Validation used 235 anonymized patient images with component-specific counts: 70 coronary, 102 calcium, 63 SAX function, 63 each for 2-, 3-, and 4-chamber LAX function, and 252 function-classification samples. Reported ranges were 97%-100% series classification, 7%-10% SAX and 5%-9% LAX volumetric MAE, 86%-99% calcium classification, 82%-94% coronary centerline performance, and 98%-100% coronary-mask performance. Cardiac CT segmentation reported LV MAE below 10%, Dice above 86%, Hausdorff distance below 9.5 mm, and EF bias 1.3% (95% CI -12 to 14); RV MAE below 18%, Dice above 85%, Hausdorff distance below 18 mm, and EF bias -5.5% (95% CI -15 to 4.4); LV-myocardium MAE below 17%, Dice above 82%, and Hausdorff distance below 15 mm.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
cvi42 Software Application regulatory performance study summary
DesignStand-Alone Performance
PopulationAdult
Scopeexact submission
Tested versionExact product version not reported; regulatory study summarized for FDA submission K242781
Samplen=235
IndependenceIndependence not established
K242781
ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K242781. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Previously acquired cardiovascular MR and CT images in DICOM format from cardiovascular MR or CT scanners; the packet limits analysis to cardiac images and states that the machine-learning modules are intended for adults.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: Accepts uploaded DICOM data and does not interface directly with acquisition equipment; results are available on screen and can be saved. The FDA packet describes stand-alone or networked use and DICOM compliance but does not establish a specific PACS, RIS, EHR, or local interface version.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Unresolved route: Not established for the exact route.
Scope: Exact FDA submission. The exact FDA decision document was reviewed on 2026-11-14 and does not state where the subject device's software runs or how it is hosted. Confirm the deployment model, hosting, data flow, and current commercial configuration with the vendor.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-11-14 ·
Returned objects
Source context, not route validation: Display and reconstruction tools plus measurements including distance, area, volume, mass, signal intensity, Agatston score, stenosis, velocity, strain, cardiac function metrics, and semi-automatic cardiac segmentation; also calcium scoring, coronary centerline analysis, vessel stenosis evaluation, lesion reporting, and key images.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: Display and reconstruction tools plus measurements including distance, area, volume, mass, signal intensity, Agatston score, stenosis, velocity, strain, cardiac function metrics, and semi-automatic cardiac segmentation; also calcium scoring, coronary centerline analysis, vessel stenosis evaluation, lesion reporting, and key images.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Accepts uploaded DICOM data and does not interface directly with acquisition equipment; results are available on screen and can be saved. The FDA packet describes stand-alone or networked use and DICOM compliance but does not establish a specific PACS, RIS, EHR, or local interface version.
Circle Cardiovascular Imaging's cvi42 page (dated 2026-05-05) states that cvi42 processes imaging data entirely within the customer's environment (hospital workstation or customer-managed server) with no data transmitted outside the institution; that the AI models are locked, frozen and encrypted when integrated into cvi42 and do not continue to learn once deployed; and that the AI does not learn from or store customer-site patient data. Vendor statement; no certification or test report was read.
Product family
Checked 2026-10-26
Vendor statement, not an attestation. The page is on circlecvi.com and describes cvi42 without naming a version, so it is family-level context.
ACR AI Central provides an exact-submission model card for cvi42 Software Application; FDA labeling remains controlling for clinical use, limitations, and performance.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
23Fields reviewed
9Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-08 - Exact FDA submission
No public price or quote for the exact K242781 configuration was established in this review.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Deployment: Not publicly available - checked 2026-11-14 - Exact FDA submission
The exact FDA decision document was reviewed on 2026-11-14 and does not state where the subject device's software runs or how it is hosted. Confirm the deployment model, hosting, data flow, and current commercial configuration with the vendor.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-09-08 - Exact FDA submission
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Monitoring: Not verified - checked 2026-09-08 - Exact FDA submission
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Authorized purpose: Support-tool image processing for quantitative cardiovascular assessment and oncologic lesion evaluation, quantification, follow-up, and documentation to aid trained healthcare professionals in diagnosis; the software does not directly generate a diagnosis or potential findings.
Modality
CT/CTA; MRI
Anatomy
Heart and major vessels for Cardio AI; oncology lesion anatomy is not further specified in the FDA statement.
Authorized purpose: DICOM/non-DICOM image and data management with optional quantitative cardiac MR and oncology lesion evaluation, quantification, follow-up, and documentation support; the software does not directly generate a diagnosis or potential findings.
Modality
CT/CTA; MRI
Anatomy
Heart and major vessels for the optional Cardio AI module; lung and liver lesions or nodules for the optional Oncology AI module; the base viewer handles broader radiological image data.
Authorized purpose: Create, review, analyze, annotate, export, and use 3D cardiac models to support reading, reporting, and therapeutic-intervention planning.
Modality
CT/CTA; MRI
Anatomy
Cardiac structures, including the aorta, atria, ventricles, pulmonary artery trunk, and right atrium/inferior vena cava structures described in the FDA performance table
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.